Gout

Latest News


CME Content


In the midst of planning Thanksgiving dinner and watching the best NFL matchups, the last thing patients want to think about is an inconvenient gout flare-up. Unfortunately, it looks like November is prime-time for the debilitating condition.

©lenetstan/Shutterstock.com

The Economic Burden of Gout

By

The indirect costs of gout can be as much as $18,362 per patient each year, research shows.

©MarcosMesaSamWordleyShutterstock.com

Fructose and Gout Don't Mix

By

Chronic consumption of sugar-sweetened beverages leads to increased BMI and gout risk, study shows.

Gout has been making quite a stir in news recently. Between a new classification system and a study showing that a common food can cause painful flares, this form of arthritis is getting quite a bit of attention. Now comes word that a drug used to treat gout could also be effective for another damaging condition.

Patients with tophaceous gout rarely develop ulcers, but when they do occur, these ulcers can be difficult to treat. This case study explores the diagnosis of and treatment options for patients with ulcerated tophaceous gout.

It may not be a surprise that having more gout flares in a year is more costly, but a recent study has quantified just how much more expensive they are.

Allopurinol's overall impact on the risk of mortality has been studied but is not yet well-understood. Now, a study has shown that the benefits from this treatment likely outweigh the risk of serious side effects.

Gout attacks really do occur more often at night, and here is proof. Theories abound as to why, but effective prophylactic treatments to reduce the risk of nocturnal exacerbations appear to be just what the doctor ordered.

A recent interest in the effects of neutrophil extracellular traps in gout tophi could shed light on inflammatory processes in other autoimmune diseases.